Stanford Starts Kindred Healthcare (KND) at Buy
More News related to KND
- Kindred Healthcare to Present at the Credit Suisse Healthcare Conference
- Kindred Healthcare (KND) Tops Q3 EPS by 11c; Guides Higher for FY09
- Kindred Healthcare Third Quarter Results Exceed Company's Guidance
- Kindred Healthcare's Third Quarter Conference Call Scheduled for November 3
- Kindred Healthcare to Present at the Oppenheimer 20th Annual Healthcare Conference
More News related to New Coverage
- Piper Jaffray Initiates Coverage on Hain Celestial Group (HAIN) with a Neutral; Upside Potential is Limited
- Piper Jaffray Initiates Coverage on Green Mountain Coffee (GMCR) with an Overweight; Several Potential Catalysts
- Piper Jaffray Initiates Coverage on B&G Foods (BGS) with a Neutral; Stock Reflects Fair Valuation
- Piper Jaffray Initiates Coverage on Del Monte Foods (DLM) with a Neutral
- Longbow Starts KR, WFMI at Buy, SWY, SVU at Neutral
Stanford Group initiates coverage on Kindred Healthcare (NYSE: KND) with a Buy rating.
Kindred Healthcare, Inc. operates as a healthcare services company in the United States.
Related Categories
New CoverageStocks Mentioned
-0.50Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
